Gold tier: mechanically validated evidence, with its primary source.
5 evidence items · page 1 / 1
5.61 timesPersons with diagnosed diabetes used 5.61 times more medications than matched comparison subjects without diabetes in Cameroon, Mali, Tanzania and South Africa during 2008–2009.
Afrique du Sud · Cameroun · Mali · Tanzaniediabète (non précisé)observed 2008–2009published 2014PloS oneeurope_pmcdocument of 3 observations
7.54 timesPersons with diagnosed diabetes had 7.54 times more outpatient visits than matched comparison subjects without diabetes in Cameroon, Mali, Tanzania and South Africa during 2008–2009.
Afrique du Sud · Cameroun · Mali · Tanzaniediabète (non précisé)observed 2008–2009published 2014PloS oneeurope_pmcdocument of 3 observations
69.8 %La prévalence de la neuropathie chez les personnes atteintes de diabète au Mali était de 69,8 % en 2020.
Malidiabète (non précisé)observed 2020HAL · Unilimdocument of 747 observations
6.2 %Une étude a observé une prévalence du diabète de 6,2 % en zones urbaines et de 2,5 % en zones rurales en Afrique de l'Ouest (Bénin, Burkina Faso, Mali, Ghana et Libéria).
Bénin · Burkina Faso · Ghana · Liberia · Malidiabète (non précisé)HAL · Unilimdocument of 224 observations
12.95 timesPersons with diagnosed diabetes consumed 12.95 times more days of inpatient treatment than matched comparison subjects without diabetes in Cameroon, Mali, Tanzania and South Africa during 2008–2009.
Afrique du Sud · Cameroun · Mali · Tanzaniediabète (non précisé)observed 2008–2009published 2014PloS oneeurope_pmcdocument of 3 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.